Financial Gravity Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Financial Gravity Asset Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$1K	Buy	131 +78	+147%	+$390	﹤0.01%	1338
2018 Q2	$0	Sell	53 -19	-26%	-$96	﹤0.01%	1706
2018 Q1	$0	Buy	+72	New	+$321	﹤0.01%	1555

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Financial Gravity Asset Management's PETX Position: Q3 2018 in Review

Financial Gravity Asset Management increased its Aratana Therapeutics, Inc. (PETX) stake by 147% in Q3 2018, buying an estimated $390 and bringing the position to 131 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

Financial Gravity Asset Management first reported a position in PETX in Q1 2018 and has held it in 3 quarters since. 100 funds tracked by Wall St. Rank hold PETX as of Q3 2018.

Financial Gravity Asset Management held 131 shares of Aratana Therapeutics, Inc. worth $1K as of Q3 2018.
Financial Gravity Asset Management bought 78 Aratana Therapeutics, Inc. shares in Q3 2018, an estimated $390.
Aratana Therapeutics, Inc. made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q3 2018, its #1338 holding.
Financial Gravity Asset Management first reported a position in Aratana Therapeutics, Inc. in Q1 2018 and has held it in 3 quarters since.
100 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2018.

Based on Financial Gravity Asset Management's 13F filing for Q3 2018, filed 31 Oct 2018.